383 related articles for article (PubMed ID: 10947214)
1. Glycopeptide resistance in coagulase-negative staphylococci.
Biavasco F; Vignaroli C; Varaldo PE
Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
Del' Alamo L; Cereda RF; Tosin I; Miranda EA; Sader HS
Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098
[TBL] [Abstract][Full Text] [Related]
3. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
[TBL] [Abstract][Full Text] [Related]
4. Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates.
Tabe Y; Nakamura A; Igari J
J Infect Chemother; 2001 Sep; 7(3):142-7. PubMed ID: 11810575
[TBL] [Abstract][Full Text] [Related]
5. Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital.
Nakipoglu Y; Derbentli S; Cagatay AA; Katranci H
BMC Infect Dis; 2005 May; 5():31. PubMed ID: 15871748
[TBL] [Abstract][Full Text] [Related]
6. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
Felmingham D; Brown DF; Soussy CJ
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
[TBL] [Abstract][Full Text] [Related]
7. Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci.
Bertin M; Muller A; Bertrand X; Cornette C; Thouverez M; Talon D
Eur J Clin Microbiol Infect Dis; 2004 May; 23(5):375-9. PubMed ID: 15112071
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
[TBL] [Abstract][Full Text] [Related]
9. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital.
Sloos JH; van de Klundert JA; Dijkshoorn L; van Boven CP
J Antimicrob Chemother; 1998 Dec; 42(6):787-91. PubMed ID: 10052903
[TBL] [Abstract][Full Text] [Related]
10. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates.
Biavasco F; Vignaroli C; Lazzarini R; Varaldo PE
Antimicrob Agents Chemother; 2000 Nov; 44(11):3122-6. PubMed ID: 11036034
[TBL] [Abstract][Full Text] [Related]
11. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
Bourgeois F; Bingen E; Lambert-Zechovsky N
Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
[TBL] [Abstract][Full Text] [Related]
12. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics].
Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K
Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772
[TBL] [Abstract][Full Text] [Related]
13. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.
Biavasco F; Giovanetti E; Montanari MP; Lupidi R; Varaldo PE
J Antimicrob Chemother; 1991 Jan; 27(1):71-9. PubMed ID: 1828799
[TBL] [Abstract][Full Text] [Related]
14. Emergence of teicoplanin-resistant coagulase-negative staphylococci.
Cercenado E; García-Leoni ME; Díaz MD; Sánchez-Carrillo C; Catalán P; De Quirós JC; Bouza E
J Clin Microbiol; 1996 Jul; 34(7):1765-8. PubMed ID: 8784585
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
Boisson K; Thouverez M; Talon D; Bertrand X
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.
Uçkay I; Bernard L; Buzzi M; Harbarth S; François P; Huggler E; Ferry T; Schrenzel J; Renzoni A; Vaudaux P; Lew DP
Antimicrob Agents Chemother; 2012 Mar; 56(3):1258-64. PubMed ID: 22155824
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
[TBL] [Abstract][Full Text] [Related]
18. Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.
Jones ME; Gesu G; Ortisi G; Sahm DF; Critchley IA; Goglio A;
Clin Microbiol Infect; 2002 Feb; 8(2):101-11. PubMed ID: 11952723
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
Mashaly GE; El-Mahdy RH
Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
[TBL] [Abstract][Full Text] [Related]
20.
Plota M; Papadimitriou-Olivgeris M; Kolonitsiou F; Tsiata E; Spiliopoulou I; Assimakopoulos SF; Marangos M
J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34559042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
